A jump-start for electroceuticals

Kristoffer Famm (), Brian Litt, Kevin J. Tracey, Edward S. Boyden and Moncef Slaoui
Additional contact information
Kristoffer Famm: Kristoffer Famm is vice-president of bioelectronics research and development at GlaxoSmithKline, Brentford TW8 9GS, UK.
Brian Litt: Philadelphia, Pennsylvania 19104, USA.
Kevin J. Tracey: Kevin J. Tracey is president of the Feinstein Institute for Medical Research, Manhasset, New York 11030, USA.
Edward S. Boyden: Cambridge, Massachusetts 02139, USA.
Moncef Slaoui: Moncef Slaoui is chairman of Global R&D and Vaccines at GlaxoSmithKline, Brentford TW8 9GS, UK.

Nature, 2013, vol. 496, issue 7444, 159-161

Abstract: Kristoffer Famm and colleagues unveil a multidisciplinary initiative to develop medicines that use electrical impulses to modulate the body's neural circuits.

Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/496159a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:496:y:2013:i:7444:d:10.1038_496159a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/496159a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().